Journal of Clinical Medicine最新文献

Background/Objectives: Insulin resistance and ambulatory blood pressure monitoring (ABPM) abnormalities represent distinct but interrelated pathways contributing to cardiovascular risk. The triglyceride-glucose (TyG) index reflects metabolic burden, whereas arterial load-captured through arterial stiffness, blood pressure variability, and morning surge-reflects hemodynamic instability. Whether the coexistence of these domains identifies a particularly high-risk ambulatory phenotype remains unclear. To evaluate the independent and combined effects of metabolic burden (TyG) and arterial load on circadian blood pressure pattern and short-term systolic blood pressure variability. Methods: This retrospective cross-sectional study included 294 adults who underwent 24 h ABPM. Arterial load was defined using three ABPM-derived indices (high AASI, high SBP-ARV, high morning surge). High metabolic burden was defined as TyG in the upper quartile. The "double-high" phenotype was classified as high TyG plus high arterial load. Primary and secondary outcomes were non-dipping pattern and high SBP variability. Multivariable logistic regression and Firth penalized models were used to assess independent associations. Predictive performance was evaluated using ROC analysis. Results: The double-high phenotype (n = 15) demonstrated significantly higher nighttime SBP, reduced nocturnal dipping, and markedly elevated BP variability. It was the strongest independent predictor of non-dipping (adjusted OR = 42.0; Firth OR = 11.73; both p < 0.001) and high SBP variability (adjusted OR = 41.7; Firth OR = 26.29; both p < 0.001). Arterial load substantially improved model discrimination (AUC = 0.819 for non-dipping; 0.979 for SBP variability), whereas adding TyG to arterial load produced minimal incremental benefit. Conclusions: The coexistence of elevated TyG and increased arterial load defines a distinct hemodynamic endotype characterized by severe circadian blood pressure disruption and exaggerated short-term variability. While arterial load emerged as the principal determinant of adverse ambulatory blood pressure phenotypes, TyG alone demonstrated limited discriminative capacity. These findings suggest that TyG primarily acts as a metabolic modifier, amplifying adverse ambulatory blood pressure phenotypes predominantly in the presence of underlying arterial instability rather than serving as an independent discriminator. Integrating metabolic and hemodynamic domains may therefore improve risk stratification and help identify a small but clinically meaningful subgroup of patients with extreme ambulatory blood pressure dysregulation.

Background/Objectives: To evaluate the predictive accuracy of intraocular lens (IOL) power calculation by ray tracing in eyes with previous radial keratotomy (RK). Methods: A consecutive series of eyes with previous RK was retrospectively analyzed. Preoperatively, all eyes underwent optical biometry to measure the axial length (AL) and anterior segment imaging by the MS-39 (CSO), which combines Placido disk corneal topography and anterior segment optical coherence tomography. The built-in ray tracing software was used to calculate the IOL power. For comparative purposes, the results of the Barrett True-K, EVO, Haigis total keratometry, and PEARL-DGS formulas were also investigated. The refractive outcomes were evaluated with Eyetemis. Results: Twenty-four eyes (24 patients) were investigated. The mean AL and keratometry were, respectively, 27.34 ± 2.88 mm and 35.53 ± 3.66 diopters (D). The mean prediction error (PE) was -0.03 ± 0.65 D (range: from -1.30 to +1.64 D). The mean and median absolute errors were 0.52 and 0.48 D, respectively. The percentages of eyes with a PE within ±0.25 D, ±0.50 D, and ±1.00 D were 29.17%, 62.50%, and 87.50%, respectively. A comparison with the other formulas was possible in 20 eyes and did not reveal any statistically significant differences; the percentage of eyes with a PE within ±0.50 D ranged from 50 to 65%. Conclusions: Ray tracing is a relatively accurate solution for calculating the IOL power in eyes with previous RK. Paraxial formulas provide similar outcomes and should be considered in these patients. The refractive outcomes of IOL power calculation in post-RK eyes are still below modern benchmarks for virgin eyes.

Background/Objectives: Subcondylar mandibular fractures represent a challenging subset of maxillofacial trauma due to their proximity to the temporomandibular joint and the facial nerve. The retromandibular approach can be performed through either an anteroparotid or a transparotid route, but comparative clinical data remain limited. This study aimed to evaluate clinical outcomes, complication profiles, and operative parameters associated with the retromandibular anteroparotid versus transparotid approach for open reduction and internal fixation (ORIF) of subcondylar fractures. Methods: A retrospective analysis was conducted on 80 consecutive patients treated for subcondylar mandibular fractures at the Department of Maxillofacial Surgery, Umberto I General Hospital, Sapienza University of Rome, between 2018 and 2025. All patients underwent ORIF via a retromandibular approach (anteroparotid or transparotid) with a minimum follow-up of 6 months. Demographic data, trauma etiology, fracture morphology (classified as simple or complex), associated fractures, surgical approach, fixation details, operative time, hospital stay, and postoperative complications were collected. Facial nerve function was clinically assessed and graded using the House-Brackmann scale. Associations between fracture type, surgical approach, number of plates, and complications were evaluated using Chi-square or Fisher's exact tests, while operative time was compared using one-way ANOVA and Kruskal-Wallis tests (p < 0.05). Results: The cohort had a mean age of 41.9 years and was predominantly male (67.5%). The anteroparotid route was used in 54 patients (67.5%) and the transparotid route in 26 (32.5%). Overall, 10 patients (12.5%) developed postoperative complications, including transient facial nerve weakness, malocclusion, visible scarring, and sialocele. All cases of sialocele occurred in the transparotid subgroup, whereas no salivary complications were observed after the anteroparotid approach. No permanent facial nerve deficits, temporomandibular joint ankylosis, or long-term facial asymmetry were recorded at 6 months. No significant association was found between surgical approach and overall complication rate, but complex fracture patterns were significantly associated with increased operative time. Conclusions: The retromandibular approach is a safe and effective option for ORIF of subcondylar mandibular fractures. Both anteroparotid and transparotid routes provided reliable exposure and stable fixation with low complication rates. The anteroparotid route appears to minimize parotid-related complications, such as sialocele, while maintaining comparable functional outcomes. These findings support the retromandibular anteroparotid approach as a valuable alternative in the surgical management of subcondylar fractures.

Background/Objectives: Endocrine therapy (ET) is a common treatment for hormone-dependent breast cancer and is associated with a significant reduction in recurrence and mortality rates. However, the decision to initiate endocrine therapy is a critical and often distressing juncture for patients. The need to weigh its survival benefits against the potential burden of side effects, including mood changes, pain, muscle stiffness, and fatigue, can render this decision-making phase a source of significant distress. The present systematic review aimed to identify and synthesize the sociodemographic and psychosocial predictors of the decision-making process related to ET adherence among women with breast cancer. Methods: A systematic literature search was conducted in three electronic databases-PubMed Central, ProQuest, and Scopus-to identify studies examining the association between sociodemographic and psychosocial factors and the decision-making process regarding ET among women with breast cancer. Inclusion criteria encompassed cross-sectional studies published between 2000 and 2025. Data were extracted and analyzed to identify recurring predictors across studies. The findings were synthesized through a narrative synthesis. Results: Twelve cross-sectional studies met the inclusion criteria, comprising a total of 8510 women diagnosed with breast cancer and undergoing ET. Ten studies (83%) identified sociodemographic variables-such as age, marital status, educational level, and ethnicity-as significant predictors of decision-making. Moreover, nine studies (75%) reported psychosocial factors, including quality of life (QoL), fear of progression, infertility concerns, and social support, as influential in the decision to initiate or continue ET. Specifically, the decision to adhere to ET is generally supported by younger age, higher education, better perceived quality of life, and greater social support. Conversely, it is hindered by lower income, lower education, fertility concerns related to marital status, and diminished quality of life. Conclusions: The findings of this review indicate that both sociodemographic and psychosocial factors play key roles in shaping women's decisions regarding adherence to ET. Understanding these predictors can facilitate decision-making and inform the development of targeted interventions aimed at improving treatment adherence and supporting patient-centered care in breast cancer treatment. The focus on decision-making processes, rather than on adherence rates, is what distinguishes this review from other systematic reviews.

The European Society of Hypertension (ESH) and the European Society of Cardiology (ESC) have recently released separate guidelines for the management of arterial hypertension, published less than 12 months apart. Many practicing physicians, especially in the primary care setting, might find it challenging to thoroughly read the two lengthy documents and, most importantly, might get confused in areas of discrepancies. This review compares the two sets of recommendations using the BEST framework, which focuses on Blood pressure (BP) measurement and monitoring, Establishing the diagnosis and classifying hypertension, Stratified patient assessment, and Therapeutic decisions, providing a structured overview of their areas of agreement and divergence and aiming at highlighting what the practicing physician should keep in mind. In general, the main recommendations made by the 2023 ESH and 2024 ESC guidelines regarding hypertension diagnosis and management present many similarities: office diagnostic threshold at 140/90 mmHg (multiple measurements and visits), primary role of out-of-office BP monitoring in confirming hypertension diagnosis and in follow-up of treated patients, cardiovascular (CV) risk assessment based on risk calculators and risk modifiers, initiation of drug treatment based on BP level and CV risk, treatment strategy based on steps and combination therapy, and treatment target for most patients of <130/80 mmHg.

Background/Objectives: The purpose of the study is to assess visual and refractive outcomes and patient satisfaction after bilateral implantation of an enhanced monofocal intraocular lens (IOL) in a monovision configuration. Methods: Prospective, monocentric, non-comparative study including adults 21 years or older, with astigmatism less than 1.50 D, who were suitable for bilateral cataract surgery targeted with -1.00 D monovision. Participants were implanted with the RayOne EMV and followed up for three months. Outcome measures included refraction, monocular and binocular uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), uncorrected and distance-corrected intermediate visual acuity (UIVA and DCIVA) at 66 cm and 80 cm, binocular defocus curve, and CatQuest-9SF questionnaire. Results: Sixty eyes of thirty patients were included. Postoperative spherical equivalent (SEQ) was -0.16 ± 0.29 D in the dominant eyes and -1.24 ± 0.43 D in the non-dominant eyes. Binocularly, mean UDVA at 4 m was -0.01 ± 0.07 and 0.1 logMAR or better in all patients. Mean binocular UIVA at 66 cm was 0.08 ± 0.08 and 0.2 logMAR or better in 92.9% of patients. Binocular UDVA was statistically significantly improved compared to monocular UDVA of the dominant eye targeted for distance (p < 0.001). Similarly, binocular UIVA was statistically significantly improved compared to monocular UIVA of the non-dominant eye targeted for -1.00 D (p < 0.001). A total of 96.6% of patients were satisfied with their sight. Conclusions: Bilateral implantation of an enhanced monofocal IOL in a monovision configuration provided excellent binocular uncorrected vision at distance and intermediate ranges, demonstrating effective binocular summation and a high level of patient satisfaction.

Diffusion-weighted imaging (DWI) has been increasingly utilized in the emergent evaluation of acute ischemic stroke (AIS) patients. DWI enhances sensitivity and specificity and enables the use of delayed reperfusion treatments in selected cases. However, DWI is not devoid of limitations. DWI-negative AIS is not uncommon in clinical practice and is reported in up to 1 of 4 AIS patients. We reviewed the relevant literature and searched the PubMed and Google Scholar databases for studies reporting on DWI-negative AIS prevalence during the 2021-2025 time period. Additionally, we included cases from our practice to highlight key points. DWI-negative AIS prevalence was 16% in one meta-analysis and ranged from 6.9% to 23.2% in identified studies that met our inclusion criteria. The biological, pathophysiological, technical, epidemiological and clinical factors that contribute to DWI-negative stroke are presented in detail. Overall, the application of diffusion imaging modalities for stroke is not bereft of blind spots despite enhanced sensitivity. Over-reliance on advanced neuroimaging and unfamiliarity with its limitations predispose DWI to errors in AIS assessment. Awareness of the predisposing factors, treatment effect, and prognosis guides appropriate decision-making, promoting good outcomes. Prospective appropriately designed trials should address the lingering questions identified, such as the association between time of imaging and DWI negativity.

Background: Thrombocytopenia (platelet count < 100 × 10⁹/L) occurs in 20-40% of critically ill patients with sepsis and is associated with adverse outcomes. Most prior studies have treated thrombocytopenia as a static risk indicator rather than a dynamic process. We investigated whether platelet recovery within 7 days provides independent prognostic information in patients with sepsis. Methods: We performed a retrospective cohort study using the MIMIC-IV database. Among 22,513 adults with sepsis admitted to intensive care units, 5401 developed thrombocytopenia within 24 h of admission and had sufficient follow-up data. The primary exposure was sustained platelet recovery to ≥100 × 10⁹/L within 7 days. The primary outcomes were 28-day and in-hospital mortality. Propensity-score matching and overlap weighting were used to adjust for demographic characteristics, comorbid conditions, illness severity, and organ-support therapies. Results: Among 5401 septic ICU patients with thrombocytopenia, 3193 (59%) achieved platelet recovery within 7 days. A total of 2056 patients (38%) recovered by day 3, and 1137 (21%) recovered between days 4 and 7. After multivariable adjustment, platelet recovery was independently associated with markedly lower mortality (adjusted risk ratio, 0.56; 95% CI, 0.53-0.67 for in-hospital death; and 0.60; 95% CI, 0.53-0.67 for 28-day death) and more than a doubling of survival time (adjusted ratio, 2.08; 95% CI, 1.65-2.63). Early and intermediate recovery conferred similar benefits. Higher baseline platelet counts, antiplatelet therapy, and heparin use were associated with recovery, whereas cirrhosis, greater illness severity, and continuous renal replacement therapy were associated with non-recovery. Conclusions: In patients with sepsis and thrombocytopenia, platelet recovery within 7 days was a strong and independent predictor of survival. Exploratory timing-stratified analyses yielded similar associations across subgroups. These findings support platelet recovery as a useful prognostic marker reflecting broader physiologic stabilization in sepsis.

Background: Aortic arch surgery using the frozen elephant trunk (FET) technique remains one of the most complex scenarios in cardiac anesthesia. The anesthesiologist plays a central role in maintaining neuroprotection, organ perfusion and hemodynamic stability during hypothermic circulatory arrest and selective cerebral perfusion. This review summarizes key anesthetic principles aimed at improving neurologic and systemic outcomes. Methods: This narrative review examines current evidence and expert recommendation on temperature and perfusion management, neuromonitoring, coagulation control and postoperative strategies specific to FET procedures. Results: Modern approaches emphasize moderate hypothermia with tailored selective cerebral perfusion, multimodal neuromonitoring and structured organ protection bundles. Evidence supports the use of physiology-guided perfusion, viscoelastic-based coagulation management and coordinated teamwork with surgical and perfusion specialists to reduce neurologic injury, bleeding and postoperative organ dysfunction. Conclusions: Anesthetic management in FET surgery requires an integrated, physiology-based strategy supported by advanced monitoring and close interdisciplinary coordination. Adoption of standardized organ-protection and perfusion protocols is essential to optimize neurologic and systemic outcomes in this high-risk population.

Background/Objectives: Functional limitations are common among older cancer survivors and tend to increase with age and survivorship duration. Physical activity (PA) associates with better functional outcomes, but little is known about how these associations vary as time passes post-diagnosis. This study examined how years since diagnosis, three types of physical activity, and their interactions associate with functional limitations in older cancer survivors. Methods: Data drawn from the 2021 National Health Interview Survey (NHIS), representing adults aged 55+ and with a prior cancer diagnosis (n = 9356; mean age = 72.17 ± 8.5 years), were studied. A four-item self-reported difficulty index (i.e., washing/dressing, walking one block, climbing stairs, and picking up/opening objects) was summed to measure functional limitations. PA was assessed using the items aligned with the United States PA Guidelines. Hierarchical regression was used to evaluate associations between functional limitations and years since diagnosis, vigorous physical activity, moderate physical activity, and strength training. Interaction effects of years since diagnosis and each activity type were also examined. Covariates were age, sex, BMI, and educational attainment. Results: Elapsed time since cancer diagnosis positively associated with functional limitations in interaction with physical behaviors, while moderate physical activity and strength training negatively associated with functional limitations. Interactions of years since diagnosis and both moderate physical activity and strength training revealed smaller increases in functional limitations. No interaction effects were observed for vigorous physical activity. Conclusions: Among older cancer survivors, the association between survivorship duration and functional limitations differs by engagement in moderate and resistance-based physical activity. These findings support the clinical importance of promoting sustainable, non-vigorous physical activity in long-term survivorship care.